Treatment for Acute Gout Flare
First-line treatment options for acute gout flares include colchicine (within 12 hours of flare onset), NSAIDs, or oral corticosteroids, with the choice based on patient-specific factors such as timing of treatment, comorbidities, and contraindications. 1
First-Line Treatment Options
Colchicine
- Dosing: 1.2 mg (two tablets) at first sign of flare, followed by 0.6 mg (one tablet) one hour later 2
- Timing: Most effective when given within 12 hours of symptom onset 1
- Contraindications:
- Severe renal impairment
- Concomitant use of strong P-glycoprotein/CYP3A4 inhibitors (e.g., cyclosporin, clarithromycin)
- Hepatic impairment
NSAIDs
- Dosing: Use maximum recommended doses for short duration
- Examples: Naproxen (500 mg twice daily for 5 days), indomethacin, ibuprofen
- Contraindications:
- Renal disease
- Heart failure
- Cirrhosis
- History of gastrointestinal bleeding
- Note: No evidence that indomethacin is more effective than other NSAIDs 1
- Consider: Adding proton pump inhibitor if GI risk factors present 1
Oral Corticosteroids
- Dosing: Prednisolone 30-35 mg daily for 3-5 days 1
- Advantages: Generally safer and lower cost than other options 1
- Contraindications:
- Systemic fungal infections
- Uncontrolled diabetes
- Active infection
Treatment Selection Algorithm
Assess timing from symptom onset:
- If <12 hours: Consider colchicine as preferred option
- If >12 hours: NSAIDs or corticosteroids may be more effective
Assess renal function:
- If severe renal impairment: Avoid colchicine and NSAIDs; use corticosteroids
- If moderate renal impairment: Avoid NSAIDs; consider dose-adjusted colchicine or corticosteroids
Assess cardiovascular risk:
- If high CV risk or heart failure: Avoid NSAIDs; prefer corticosteroids or colchicine 3
Assess GI risk:
- If history of GI bleeding or ulcers: Avoid NSAIDs; use corticosteroids or colchicine
- If using NSAIDs: Consider adding PPI for gastroprotection 1
For severe, polyarticular flares:
Additional Treatment Options
For patients with contraindications to all first-line therapies:
- IL-1 inhibitors (e.g., anakinra, canakinumab) may be considered 1, 4
- More expensive than traditional options
- Contraindicated in active infection
Common Pitfalls and Caveats
Delayed treatment: Early intervention is crucial for optimal response. Educate patients to self-medicate at first warning symptoms ("pill in pocket" approach) 1
Incorrect colchicine dosing: High-dose colchicine regimens increase adverse effects without improving efficacy 1
Initiating urate-lowering therapy during acute flare: This can worsen or prolong the flare; focus on anti-inflammatory treatment first
Overlooking prophylaxis: When starting urate-lowering therapy after flare resolution, provide prophylaxis with colchicine 0.5-1 mg daily or low-dose NSAIDs for 6 months 1
Failing to address lifestyle factors: Advise patients to avoid alcohol (especially beer), sugar-sweetened drinks, and purine-rich foods (organ meats, shellfish) 1, 5
By following this evidence-based approach to treating acute gout flares, you can effectively manage pain and inflammation while minimizing adverse effects based on individual patient factors.